Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

ProMetic Life Sciences Inc T.PLI

Sector: Healthcare | Sub-Sector: Biotechnology

ProMetic Life Sciences Inc is a biopharmaceutical company. The Company is engaged in bioseparations, plasma-derived therapeutics and small-molecule drug development.
Price: $2.26 | Change: +$0.03 | %Change: +1.35%
Volume: 606,903 | Day High/Low: 2.29/2.21 | 52 Week High/Low: 2.87/1.17
View modes: 
0 stars

RE:Prometic as a top pick on BNN

MACQUARIE very large corp. Big Accounts  rate and reply
0 stars

RE:Prometic as a top pick on BNN

I did not see it , but interesting if we can get the details of such ..... re-read the RBC report. Very detailed . they did their home work over the top ! They are very positive on PLI in the end with...read more
0 stars

In the Future...

If you want to see where Prometic is going, see Baxalta (BXLT-N) at $32USD! Worth the wait IMO.  rate and reply
0 stars

Prometic as a top pick on BNN

I just caught a quick piece of this and don't even have the company name properly but this morning on BNN they presented 5 top picks for Canadian stocks with US exposure and 10 top picks of Canadian...read more
5 stars

PLi strategy

I have touched on this topic before however it seems relevant to bring it up once more.Everything about this company deals with the future...everything. Future products,facilities being bought or...read more
0 stars

RE:Bep

wow, I'm getting dyslexic...obviously 4050, not what I put there...  rate and reply
0 stars

Bep

Bep, I hope you are right about getting some Metabolic Syndrome data in August. I'm not banking on it for my investment thesis right now, as I don't want to be disappointed if it doesn't happen on the...read more
0 stars

RE:RE:RE:RE:Interesting comments in RBC report

Dibah, you point is fair, and that is why I feel like Prometic has plans in the short-to-mid term to do something significant at Emergent...otherwise it makes no sense to increase the spending as they...read more
0 stars

RE:RE:RE:RE:Interesting comments in RBC report

D42, from what I understand PLI is renting space from Emergent not buying product. The next 6 months or so will involve cash burn as it refits its part of Emergent's plant in Winnipeg witht he PPPS...read more
0 stars

RE:RE:RE:Interesting comments in RBC report

plilong: "It still does fall short of my expectations on Emergent though, as I feel like PLI has very near term plans which may be significant. Otherwise, why would they sign a contract now that...read more
0 stars

RE:RE:RE:Interesting comments in RBC report

Plilong, I agree PLI gave every indication that Winnipeg would be operational by year end and you would think would be put to producing various proteins for trials -- especially plasminogen, IVIG...read more
0 stars

level 2 at 2:30 pm

My last post for today # Orders Shares Bid Ask Shares # Orders 9 4600 2.270 2.280 43200 ...read more
0 stars

level 2 at 1:46 pm

# Orders Shares Bid Ask Shares # Orders 12 8700 2.270 2.280 3100 3 9 55300 ...read more
0 stars

level 2 at 12:44 pm

# Orders Shares Bid Ask Shares # Orders 10 5900 2.230 2.240 500 4 10 5100 ...read more
0 stars

RE:RE:Interesting comments in RBC report

Bep and nomade, thx for the references on Emergent, I had missed them in my reviews. It still does fall short of my expectations on Emergent though, as I feel like PLI has very near term plans which...read more
5 stars

RE:Interesting comments in RBC report

His base case of $3.50 includes 4050 at $.76 and assumes 4050 is approved for IPF (pg#2 Target price/base case). Am I reading this correctly?---is an approved 4050 for IPF, even base case , not over...read more
5 stars

Interesting comments in RBC report

The following are a few comments in the RBC report I found interesting. The comments 0n pages 49 and 54 are particularly interesting. The report does comment on the Emergent Solutions deal in a few...read more
4 stars

RE:RE:RE:RE:RE:rbc does confirm 3.50 Price Target, with up side to 6.00 -

Hi plilong, one of the mention you missed is on page 39 , Exhibit 31: Manufacturing capacity overview  have a good day Nomade  rate and reply
0 stars

RE:RE:RE:RE:rbc does confirm 3.50 Price Target, with up side to 6.00 -

Fisher, he does seem to have a good record in biotechs for picking winners. I think his report understates a few things though, maybe he does this purposely to stay conservative, but I found the...read more
0 stars

level 2 at 9:55 am

My last post for this morning # Orders Shares Bid Ask Shares # Orders 6 17200 2.210 2.230 10000...read more